Mark van Oene - 27 Feb 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Reporting relationship: Chief Operating Officer
Issuer ticker: PACB
Reported as of: 27 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2026, 18:13:04 UTC
Prior SEC filing: 19 Feb 2026
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Michele Farmer, Attorney-in-fact

Key filing fact

Mark van Oene filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 03 Mar 2026.

Key facts

This page summarizes Mark van Oene's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 18:13.

Change

Previous filing in this sequence was filed on 19 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001707477 Primary reporting owner

Van Oene Mark

Relationship: Chief Operating Officer
Address: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,, 1305 O'BRIEN DRIVE, MENLO PARK
Signature: /s/ Michele Farmer, Attorney-in-fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PACB transaction

Common Stock

Award

Transaction value: $0
Shares: +500,000
Change %: +29%
Price: $0.000000
Shares after: 2,242,638
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PACB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,000,000
Change %
Price: $0.000000
Shares after: 1,000,000
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000,000
Exercise price: $1.68
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2027, 2028, and 2029, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Footnote F2

The shares subject to the option will vest in 36 equal monthly installments beginning on March 27, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

SEC remarks

Chief Operating Officer